Immuneering Corporation (IMRX) PT Raised to $30 at Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Jay Olson raised the price target on Immuneering Corporation (NASDAQ: IMRX) to $30.00 (from $21.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
